During the recent session, Gossamer Bio Inc (NASDAQ:GOSS)’s traded shares were 0.89 million, with the beta value of the company hitting 1.95. At the last check today, the stock’s price was $0.93, reflecting an intraday loss of -1.29% or -$0.01. The 52-week high for the GOSS share is $1.88, that puts it down -102.15 from that peak though still a striking 51.61% gain since the share price plummeted to a 52-week low of $0.45. The company’s market capitalization is $209.74M, and the average trade volume was 2.34 million shares over the past three months.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Gossamer Bio Inc (GOSS) registered a -1.29% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.29% in intraday trading to $0.93, hitting a weekly high. The stock’s 5-day price performance is 63.09%, and it has moved by 55.95% in 30 days. Based on these gigs, the overall price performance for the year is -30.29%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gossamer Bio Inc (GOSS) estimates and forecasts
Statistics show that Gossamer Bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. Gossamer Bio Inc (GOSS) shares have gone up 6.80% during the last six months, with a year-to-date growth rate more than the industry average at 64.41% against 15.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 11.99%. While earnings are projected to return 71.53% in 2024, the next five years will return 5.20% per annum.
GOSS Dividends
Gossamer Bio Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
